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Abstract: Compared to imaging in the visible and near-infrared regions below 900 nm, 
imaging in the second near-infrared window (NIR-II, 1000—1700 nm) is a promising 
method for deep-tissue high-resolution optical imaging in vivo mainly due to the reduced 
scattering of photons traversing through biological tissues. Herein, semiconducting 
single-walled carbon nanotubes with large diameters were used for in vivo fluorescence 
imaging in the long-wavelength NIR region (1500—1700 nm, NIR-IIb). With this 
imaging agent, 3-4 μm wide capillary blood vessels at a depth of about 3 mm could be 
resolved. Meanwhile, the blood-flow speeds in multiple individual vessels could be 
  
 
mapped simultaneously. Furthermore, NIR-IIb tumor imaging of a live mouse was 
explored. NIR-IIb imaging can be generalized to a wide range of fluorophores emitting 
at up to 1700 nm for high-performance in vivo optical imaging. 
Fluorescence-based optical imaging is indispensable to investigating biological 
systems with high spatial and temporal resolution.
[1]
 However, a formidable challenge to in 
vivo fluorescence imaging of live animals has been the limited depth of penetration and 
inability of high-resolution imaging through live tissues owing to both the absorption and 
scattering of photons. To circumvent this problem, we and others have recently explored in 
vivo fluorescence imaging in the second near-infrared window (NIR-II, 1000—1700 nm) to 
benefit from reduced photon scattering and achieve higher imaging resolution deeper in the 
body than with traditional NIR imaging (NIR-I, 750—900 nm).[2] Nevertheless, the NIR-II 
fluorophores used thus far mainly emit below about 1400 nm, which is still not optimal from 
the tissue scattering point of view. Although in vivo fluorescence imaging at longer 
wavelengths would further reduce scattering, increased water absorption upon approaching 
the infrared region could diminish the intensity of light passing through biological tissues, 
which is a valid concern that has deterred in vivo fluorescence imaging in the long 
wavelength NIR region. Another consideration for the development of in vivo fluorescence 
imaging in the long NIR window is the lack of biocompatible emitters with sufficient 
brightness. To date, most NIR-II in vivo fluorescence imaging has been based on high-
pressure carbon monoxide conversion (HiPCO) single-walled nanotubes (SWNTs) with a 
small diameter distribution of 0.7--1.1 nm, emitting band-gap fluorescence in the range of 
1000—1400 nm.[2c,g,h,3] We expect that SWNTs with larger diameters, such as SWNTs grown 
by the laser vaporization method originally developed by Smalley,
[4]
 could enable high-
resolution fluorescence imaging in the longer-wavelength region. 
The long wavelength NIR-II region near 1600 nm offers a balance of photon-
scattering and water-absorption effects, promising to significantly enhance the performance of 
  
 
fluorescence imaging in vivo, by achieving both improved penetration depth and imaging 
resolution. As shown in the absorption spectrum of water and the extinction spectra of 
biological tissues (Figure 1a), the near 1600 nm region resides in a local valley between a 
water vibrational OH stretching overtone absorption peak at approximately 1450 nm and the 
edge of an increasing water absorption combination band beyond 1700 nm. Thus, the 
fluorescence imaging window near 1600 nm offers a local minimum in the water absorption 
spectrum to minimize attenuation of the fluorescence signal caused by water dominant in 
biological tissues. On the other hand, as photon scattering scales as λ-α (α=0.2--4 for different 
tissues),
[5]
 the near 1600 nm window provides the lowest photon scattering in the entire NIR-
II window (without water absorption dominance), useful for high-resolution, deep-tissue 
biological imaging. 
We herein report the successful in vivo fluorescence imaging (under 808 nm 
excitation) in the 1500—1700 nm NIR-II window (referred to as the "NIR-IIb" window). 
Semiconducting SWNTs with improved fluorescence brightness are chemically enriched from 
unsorted SWNTs synthesized by laser vaporization. The NIR-IIb imaging window affords an 
in vivo vascular imaging spatial resolution down to approximately 4 μm at a depth of up to 
about 3 mm in the mouse hindlimb and brain with intact skull and scalp. Simultaneous single-
vessel-resolved blood-flow speed mapping for multiple hindlimb arterial vessels is achieved 
by video-rate fluorescence imaging in the NIR-IIb region. Furthermore, high-performance 
NIR-IIb tumor imaging with clear and sharp resolution is explored. 
The SWNT NIR-IIb emitters with a diameter range of approximately 0.96--1.24 nm 
were synthesized by laser vaporization (LV).
[6]
 Changing the furnace temperature during LV 
synthesis from 950°C to 1125 °C changed the SWNT average diameter from approximately 
0.9 to 1.4 nm, allowing us to identify the SWNTs grown at 950 °C to be the brightest for 
imaging in the NIR-IIb window (Supporting Information, Figure S1). Compared to the 
previously widely used HiPCO SWNTs, the LV nanotubes exhibited higher fluorescence in 
  
 
the 1500—1700 nm region owing to the smaller band gaps and the larger average diameter 
(Figure S2; quantum yield measurements are shown in Figure S3).
[4b]
 The LV SWNTs grown 
at 950 °C were then suspended by sonication and sorted through a chromatography column to 
enrich the semiconducting SWNTs (see the Method Section in the Supporting 
Information).
[2a,7]
 Compared to the raw material, the resulting semiconducting LV SWNTs 
exhibited enhanced S11/S22 (ca. 700—1800 nm) peaks and reduced M11 peaks (ca. 500—700 
nm) in the UV/Vis/NIR absorption spectra (Figure 1c), indicating successful enrichment of 
the semiconducting LV SWNTs needed for biological imaging with sufficiently bright 
fluorescence in the NIR-IIb window (Figure 1b,d). 
The semiconducting enriched LV SWNTs were stably suspended in aqueous 
biological solutions with highly biocompatible surface coatings by employing an exchange 
functionalization method (see the Supporting Information).
[2g]
 We evaluated the wavelength-
dependent non-invasive fluorescence imaging of mouse brain vessels at depths of up to 3 mm 
through the intact scalp and skull of C57Bl/6 mice (after shaving to remove hair) by 
intravenously injecting indocyanine green (ICG, emitting in the NIR-I region) or a mixture of 
biocompatible HiPCO and semiconducting LV SWNTs (Figure 2a,c). The images were 
recorded using a liquid-nitrogen-cooled 2D InGaAs camera (Princeton Instruments, detection 
range below ca. 1700 nm), which showed quantum efficiencies below 30% at wavelengths 
above 1600 nm;
[8]
 therefore, most of the NIR-IIb signals recorded in this work were within 
the 1500—1600 nm region. We measured the signal-to-background ratios (SBRs) by plotting 
the cross-sectional intensity profiles of the same vessel imaged in the NIR-I (850-900 nm), 
NIR-II (1000—1700 nm), and NIR-IIb (1500—1700 nm) windows (Figure 2d, f). The SBR 
obtained by imaging in the NIR-IIb window was found to be higher than for the NIR-I and 
NIR-II windows (4.50 in NIR-IIb vs. 2.01 in NIR-II and 1.19 in NIR-I), suggesting that in 
vivo imaging beyond 1500 nm benefits from increased signal-to-background ratios. We also 
compared the photon scattering effects in the NIR-II and NIR-IIb windows and a previously 
  
 
defined NIR-IIa region (1300—1400 nm; Figure 1a)[2b] by performing phantom studies using 
both chicken breast (Figure S4) and intralipid (a scattering medium; Figure S5), showing the 
benefit of minimized photon scattering in the long-wavelength NIR-IIb region for 
fluorescence imaging with deep penetration. 
We also performed high-magnification microscopic vessel imaging of both mouse 
hindlimb and brain with a pixel size of 2.5 μm in the NIR-IIa and NIR-IIb regions. By 
measuring the Gaussian-fitted full width at half maximum (FWHM) of the cross-sectional 
intensity profiles of the features, we found that the apparent widths of the same hindlimb 
blood vessel imaged at a depth of approximately 3 mm in the NIR-IIa (marked by a green 
line, Figure 3a) and NIR-IIb (marked by a green line, Figure 3b) were 9.7 μm and 6.3 μm, 
respectively, suggesting an improved spatial resolution in the longer-wavelength NIR-IIb 
window (Figure 3c). Also, we evaluated the SBRs of a blood vessel (marked by white lines, 
Figure 3a,b)imaged in both windows. A higher SBR of 3.85 was obtained in the NIR-IIb than 
in the NIR-IIa window (1.56) for the same blood vessel (Figure 3d). The smallest vessel 
resolved by NIR-IIb fluorescence imaging in the mouse hindlimb showed an apparent width 
(i.e., FWHM) of approximately 3.7 μm at a depth of about 2.6 mm (Figure 3e,f). 
We then compared the performance of high-magnification cerebrovascular imaging in 
the NIR-IIa
[2b]
 and NIR-IIb regions. Many vessels imaged in the NIR-IIb window showed 
generally improved feature sharpness (Figure 3i; FWHM ca. 5.4 μm in NIR-IIb vs. ca. 9.4 μm 
in NIR-IIa for the same blood vessel; green lines in Figure 3g,h) and increased SBRs (Figure 
3j; 7.44 in NIR-IIb vs. 4.91 in NIR-IIa for the same vessel; white lines in Figure 3g,h). A 
small vessel with a FWHM width down to about 4 μm was measured in the NIR-IIb region at 
a depth of approximately 2.8 mm through the intact scalp and skull, achieving micrometer 
resolution for in vivo brain fluorescence imaging at >2 mm depth (Figure 3k,l). The imaging 
depth was determined throughout this work by recording the vertical axis travel distance of 
the microscopic objective with the surface of the skin set to be a depth of zero. Ex vivo mouse 
  
 
tissue imaging was also performed to study the scattering effects in vessel size measurements 
in the NIR-IIb region (Figure S6). 
To perform video-rate fluorescence imaging of blood vessels in the mouse hindlimb in 
the NIR-IIb region, we injected a 200 μL solution of exchanged semiconducting LV SWNTs 
into the tail vein of an athymic nude mouse and performed NIR-IIb fluorescence imaging at a 
speed of 4.6 frames per second (Movie S1). Upon injection, blood flow into the femoral artery 
was clearly observed by video-rate imaging (Figure 4a). Aside from the main femoral artery, 
blood flow into numerous smaller, high-order arterial vessel branches was also observed 
(Figure 4b,c and Movie S1). These smaller vessels were deeper in the body than the femoral 
artery and were difficult to resolve by imaging in the 1000—1400 nm[2c] or 1500-1700 nm 
(Figure S7) range using HiPCO SWNTs. The blood-flow speeds in various arterial vessels 
were quantified from video-rate imaging (Movie S1) by plotting the distance travelled by the 
signal front versus time (Figure S8),
[2c]
 affording a spatially resolved blood flow map showing 
blood flow speeds of approximately 22.6 mm s
-1
 in the femoral artery and 1.1 to 4.8 mm s
-1
 in 
the smaller arterial branches (Figure 4f). To the best of our knowledge, this is the first time 
that blood flow velocities over a broad range of 1—20 mm s-1 in multiple vessels of mice 
were mapped simultaneously. Blood flow velocimetry over such a broad dynamic range from 
about 1 mm s
-1
 to >20 mm s
-1
 with spatially resolved individual vessels is hard to achieve 
with other standard techniques, such as laser Doppler and ultrasonography, which suffer from 
low spatial resolution, speckle artifacts, and a small dynamic range.
[2c,3c,9]
 
The femoral veins were observed at about 26 s post injection (p.i.; Figure 4e), as these 
vessel structures became fluorescent in the NIR-IIb region owing to the blood flow 
completing a systemic circulation cycle in the hindlimb. Principal component analysis (PCA) 
of the video-rate image frames was performed to group the image pixels with similar time 
variance into distinct components, clearly identifying the various arterial branches and 
differentiating them from the venous vessels (Figure 4f).
[2c,3a,10]
 
  
 
Lastly, we explored the NIR-IIb emitting SWNTs for in vivo tumor imaging. After 
intravenously injecting exchanged semiconducting LV SWNTs into a balb/c mouse bearing 
two subcutaneous 4T1 murine breast tumors, we performed video-rate (4.6 frames per 
second) NIR-IIb fluorescence imaging of the mouse under 808 nm excitation (Movie S2). 
Because of the pulmonary circulation, an intensity spike in the lungs (a deep organ in mice) 
was clearly resolved after injection into the tail vein (Figure 5b,c). Afterwards, NIR-IIb 
signals in the major organs (such as the kidneys) in the systemic circulation were clearly 
observed (Figure 5d,e). The vascular structures surrounding the tumors started to appear in a 
prominent manner at about 3.9 s p.i. (Figure 5e,f). These deep vessels were difficult to clearly 
resolve by imaging in shorter-wavelength regions owing to scattering by muscles and other 
tissues atop (Figure S10).
[3b]
 Registration of the inner organs and vessels was evident by 
applying PCA to the frames of the video-rate movie (Figure 5g). Over the SWNT blood 
circulation (half-life of about 5.6 h; Figure S11),
[11]
 the nanotubes gradually accumulated 
within the tumors owing to the enhanced permeability and retention (EPR) effect (Figure 
5h).
[3b,12]
 Aside from tumor uptake, the SWNTs were mainly accumulated in the liver and 
spleen of the reticuloendothelial system (RES) at seven days post injection (Figure S11). 
In conclusion, we have shown that the long-wavelength NIR imaging window of 
1500—1700 nm is advantageous for in vivo fluorescence imaging as photon scattering is 
minimized. Water absorption is slightly higher in the NIR-IIb than in the traditional NIR 
window, but the absorption effects can be overcome with sufficiently bright fluorophores. 
This is an approach worth taking as scattering problems cannot be easily solved or avoided 
unless longer-wavelength photons are detected. NIR-IIb imaging offers the lowest light 
scattering among all the NIR sub-regions examined, affording high spatial resolution, deep 
tissue penetration, and high signal/background ratios for in vivo biological imaging. The 
results here are not limited to nanotube fluorophores, and should be generalized to other 
  
 
agents emitting in the region up to 1700 nm, especially for fluorophores with much higher 
quantum yields, for further enhancing NIR-IIb imaging capabilities. 
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Figure 1 Semiconducting LV SWNTs for fluorescence imaging in the NIR-IIb region. a) 
Optical absorption spectrum of water and extinction spectra of mouse skin and mouse muscle. 
b) NIR fluorescence spectra of HiPCO and semiconducting LV SWNTs upon 808 nm 
excitation. c) Optical absorption spectra of pristine and separated semiconducting LV 
SWNTs. Photoluminescence (inset, left) and optical (inset, right) images of semiconducting 
LV SWNTs are also shown. d) The photoluminescence versus excitation (PLE) map of 
semiconducting LV SWNTs shows bright emission in the NIR-IIb region. 
 
 
 
  
 
 
Figure 2 Fluorescence images of the cerebrovasculature of mice (n=2) without craniotomy in 
the NIR-I (a), NIR-II (b), and NIR-IIb (c) regions, with the corresponding SBR analysis 
shown in (d)--(f). Scale bars: 2 mm. 
 
 
 
 
 
  
 
 
Figure 3 High-magnification vessel imaging of the hindlimb and brain of mice in the NIR-IIa 
and IIb windows. a,b)High-magnification microscopic images of the hindlimb vessels (n=2) 
at an imaging focal depth of 3 mm taken in the NIR-IIa and NIR-IIb windows, with the vessel 
FWHM width (green lines in a, b) and SBR (white lines in a, b) analysis shown in (c) and (d), 
respectively. The background signals for the SBR analysis were evaluated by averaging the 
baseline signals in the cross-sectional intensity profiles. e, f)A small blood vessel resolved by 
imaging in the NIR-IIb region. Similar vessel width and SBR analysis of the high-
magnification cerebrovascular images in the NIR-IIa (g) and NIR-IIb (h) regions are shown in 
(i) and (j). k, l) A NIR-IIb fluorescence cerebrovascular image resolving a small vessel. Scale 
bars: 40 μm. 
 
  
 
 
Figure 4 Video-rate NIR-IIb fluorescence imaging of mouse hindlimb vessels (n=3) and 
dynamic-contrast-based vessel type differentiation. a--e) Time-course NIR-IIb hindlimb 
fluorescence images after injection of semiconducting LV SWNTs into the tail vein of an 
athymic nude mouse. f) PCA overlaid image showing the differentiation of arterial (red) and 
venous (blue) vessels. The blood-flow velocities in the femoral artery and small, higher-order 
arterial vessels are also given. Scale bar: 2 mm. 
 
 
 
  
 
 
Figure 5 In vivo video-rate NIR-IIb tumor imaging in live mice (n=2). a--f) Time-course NIR-
IIb fluorescence images of the tumor-bearing mice after intravenous injection of exchanged 
semiconducting LV SWNTs. g) Overlaid PCA image of the early image frames differentiating 
inner organs and the vascular structures surrounding tumors. h) A NIR-IIb fluorescence image 
of the tumor-bearing mouse taken at 20 h p.i., showing the high uptake in the tumor area that 
is due to the EPR effect. Scale bar: 4 mm. 
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Method 
 
Synthesis of laser vaporization SWNTs. Laser vaporization synthesis of SWNTs was 
performed by methods described previously.
[1]
 Briefly, a 10-g solid target was prepared from 
graphite (Alfa Aesar, 2 – 15 μm) that was intimately mixed with 3 wt.% each nickel and 
cobalt powder. 10 g of the target material was pressed into a cylindrical 1 inch pellet and 
placed into the center of a quartz tube that was surrounded by a tube furnace for maintenance 
of the reaction temperature. The inert reaction environment was established by maintaining a 
flow of 150 standard cm
3
/min of nitrogen gas, at a regulated pressure of 500 Torr. A 
Continuum PowerLite II 1064 nm Nd:YAG laser, running without Q-switching, was used to 
vaporize the target, and the power density was kept at ~100 W/cm
2
. Different reaction 
temperatures (950, 1000 and 1125°C) were used in separate runs to tune the diameter 
distribution for optimal fluorescence signal in the NIR-IIb window. 
Separation of semiconducting laser vaporization SWNTs and biocompatible 
functionalization. 3 mg of laser vaporization (LV) SWNTs grown at 950 °C were sonicated 
in water with 1 wt.% sodium cholate (SC) for 5 h. The suspension was ultracentrifuged at 
300,000g for 30 min to remove large bundles and aggregates. The supernatant was mixed 
with 1 wt.% sodium dodecyl sulfate (SDS) with a volume ratio of 2:3. The resulting solution 
was then added to a filtration column filled with ~20 ml of ally dextran-based size-exclusion 
gel (Sephacryl S-200, GE Healthcare).
[2]
 A mixture surfactant solution of 0.6 wt.% SDS /0.4 
wt.% SC was used to wash the column to remove the metallic nanotubes, leaving mainly 
semiconducting LV SWNTs in the column. The semiconducting LV SWNTs were collected 
by eluting the column with a solution of 1 wt.% SC. To make the SWNTs biocompatible, 1 
mg/ml of (1,2-distearoyl-sn-glycero-3-phosphoethanolamine–N-[methoxy(polyethylene 
glycol)5000] (DSPE-mPEG(5k)) was added to the separated semiconducting LV SWNTs. 
After 2 min of sonication, the mixture was transferred to a 3,500 Da membrane (Fisher) for 
dialysis of four to five days with 5~6 water changes per day. The resulting biocompatible 
semiconducting LV SWNTs were then concentrated and centrifuged to remove any 
aggregates formed during dialysis before injection for fluorescence imaging. For video-rate 
NIR-IIb imaging, solutions of 200 µL of semiconducting LV SWNTs (0.43 mg/mL, 4.3 
mg/kg of body weight) were used as fluorescent contrast agents. 
Ultraviolet-Vis-NIR absorbance spectrum measurements. A Cary 6000i UV-Vis-NIR 
spectrophotometer was used for Ultraviolet-Vis-NIR absorbance spectrum measurements. The 
water absorption was measured using 1mm path cuvette (Starna Cells). 
Photoluminescence versus excitation map measurements. Photoluminescence versus 
excitation map was measured by a home-built NIR spectroscopy setup upon an excitation 
source of a 150 W ozone-free xenon lamp (Oriel). Emission light was filtered by long-pass 
filters and detected using a spectrometer (Acton SP2300i) equipped with an InGaAs linear 
array detector (Princeton OMA-V).  
NIR fluorescence emission spectrum measurements. The NIR fluorescence spectra were 
measured using the same home-built NIR fluorescence spectrometer. The excitation was 
provided by an 808-nm fiber-coupled diode laser (RPMC Lasers) and filtered with selected 
short-pass filters. The excitation light was directed to pass through a 1-mm path cuvette 
(Starna Cells) containing either HiPCO SWNT solution or semiconducting LV SWNT 
solution. The emission light was filtered using a 900-nm long-pass filter (Thorlabs) to reject 
the excitation light and then directed into the fluorescence spectrometer equipped with the 
  
 
linear InGaAs detector. All the raw emission spectra in this study were corrected for the 
detector sensitivity and extinction features of the filters.  
Phantom study using chicken breast or intralipid. The excitation light was provided using 
the 808 nm fiber-coupled diode laser (RPMC Lasers) at a power density of 0.14 W/cm
2
. A 
capillary tube was filled with a mixture of HiPCO and semiconducting LV SWNTs to afford 
fluorescence emission in the entire 1000-1700 nm region. The capillary tube was then inserted 
under a piece of chicken breast with a thickness of 4 mm and the fluorescence images of the 
tube were taken in NIR-II, IIa and IIb regions using a liquid-nitrogen-cooled 2D InGaAs 
camera (Princeton Instruments, quantum efficiency curve up to 1700 nm). Different emission 
filter sets were used to select various subregions (900 nm and 1000 nm long-pass filters for 
NIR-II region, 1000 nm, 1300 nm long-pass filters and 1400 nm short-pass filter for NIR-IIa 
region, 1100 nm and 1500 nm long-pass filters for NIR-IIb region). In another phantom study, 
a capillary tube filled with a mixture of HiPCO and semiconducting LV SWNTs was 
immersed in a highly scattering medium, intralipid,
[3]
 at different depths and the images of the 
tube were taken in various NIR subregions (NIR-II, NIR-IIa, NIR-IIb). The same emission 
filter set, 2D InGaAs camera and 808 nm excitation described previously were used for this 
phantom study. 
Low-magnification NIR fluorescence imaging of mouse brain and hindlimb vessels. For 
blood vessel imaging in brain and hindlimb, mouse was mounted on an imaging stage beneath 
the laser. To compare the wavelength-dependent brain imaging quality (n=2), different 
emission filters were used to select the collection range for NIR-I (850 nm long-pass filter and 
900 nm short-pass filter), NIR-II (900 nm and 1000 nm long-pass filters), NIR-IIb regions 
(1100 nm and 1500 nm long-pass filters), respectively. The excitation power density is 0.14 
W/cm
2 
at 808 nm. Two achromats (200 mm and 75 mm, Thorlabs) were used to direct and 
focus the emission light onto the 2D InGaAs camera with 320 x 256 pixels. NIR-IIb video-
rate hindlimb fluorescence images (n=3) were acquired with LabVIEW software with an 
exposure time of 200 ms plus a 19-ms overhead time in the readout. The emitted fluorescence 
from the mice was filtered using an 1100 nm long-pass filter and a 1500 nm long-pass filter to 
select the range of NIR-IIb region. To perform principal component analysis (PCA), early 
image frames immediately after injection were loaded into an array using MATLAB 
software.
[3-4]
 Pixels showing up later in the video were color-coded in blue to represent 
venous vessels while pixels showing up earlier in the video were color-coded in red to 
represent arterial vessels in the overlaid PCA image. 
High-magnification microscopic imaging of hindlimb and brain vessels. The 808 nm 
excitation laser and 2D InGaAs camera were the same as mentioned previously. The mouse 
(n=2), placed on a stereotactic stage, was imaged through a 10X objective (Bausch & Lomb) 
to afford a pixel size of 2.5 µm. The axial travel distance of the 10X objective, recorded by 
the readout of a motorized 3D translational stage, was used to determine the imaging depth 
after correcting for the different refractive indices of tissues. 
NIR-IIb fluorescence tumor imaging. Balb/c mice (n=2) were shaved and inoculated with 
~2 million 4T1 murine breast tumor cells for each tumor site (left and right) on the back. 
After ~ one week post inoculation (with an average tumor size of ~30 mm
3
), video-rate (4.6 
frames/second) NIR-IIb fluorescence tumor imaging was recorded after injection of NIR-IIb 
emitting semiconducting LV SWNTs using the same 808 nm excitation laser, 2D InGaAs 
camera and NIR-IIb region emission filters described previously (under a lower magnification 
than hindlimb or brain imaging). PCA was performed to group the inner organs and vessels 
by loading the early frames of video-rate imaging.  
Quantum yield (QY) measurement of semiconducting laser vaporization SWNTs. The 
QY measurement was carried out using IR-26 in 1,2-dichloroethane (DCE) as reference (QY 
= ~0.1%)
[5]
 under the excitation of an 808-nm laser.
[6]
 A series of solutions of IR-26 in DCE 
with absorbance values at 808 nm to be ~ 0.10, ~ 0.08, ~ 0.06, ~0.04 and ~0.02 were prepared 
  
 
respectively. Optical absorbance spectra of the five solutions were measured using the method 
described previously (with a 1-cm path cuvette from Starna Cells). To measure the 
fluorescence spectra upon the 808-nm excitation (with a 1-cm path cuvette), the NIR emission 
light was filtered by the 900 nm long-pass filter and collected in the range of 900 to 1800 nm. 
Same solution preparation, absorption and fluorescence spectra measurements were 
performed for semiconducting laser vaporization SWNTs. All the raw emission spectra were 
corrected for the detector sensitivity and extinction features of the emission filter. The 
corrected emission spectra were then integrated in the range of 900 to 1800 nm. For both IR-
26 in DCE and semiconducting laser vaporization SWNTs, the integrated fluorescence 
intensities of five fluorescence spectra were plotted against the actual absorbance values 
measured at 808 nm from optical absorbance spectra and the two slopes were obtained by 
linear fitting. The QY of semiconducting laser vaporization SWNTs was estimated to be ~ 
0.01%, based on the following calculation:  
 
 
 
Where QYSWNTs is the QY of semiconducting laser vaporization SWNTs, QYref is the QY of 
IR-26 in DCE (~0.1%), nSWNTs and nref are the refractive indices of water and DCE. 
Mouse handling and injection. C57Bl/6 mice (with hair on the scalp removed), athymic 
nude mice and balb/c mice (with hair on the back removed) were used for brain vessel 
imaging, hindlimb vessel imaging and tumor imaging respectively. For a typical NIR-IIb 
fluorescence imaging experiment, a mouse was anaesthetized by inhalation of 2.5 % 
isoflurane with 2 L·min
-1 
of oxygen and injected with 200 µL of semiconducting laser 
vaporization SWNTs at a concentration of 0.43 mg/mL. All procedures of mouse handling 
were approved by Stanford Institutional Animal Care and Use Committee (IACUC) protocols. 
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Figure S1. NIR-IIb fluorescence brightness comparison of laser vaporization SWNTs (LV 
SWNTs) grown at 950 ˚C (a), 1000 ˚C(b) and 1125 ˚C (c) upon an 808 nm excitation on the 
per mass basis
[2a]
 is shown in (d). 
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Figure S2. NIR-IIb brightness comparison of HiPCO SWNTs (a), pristine LV SWNTs (b) 
and separated semiconducting LV SWNTs (c) on the per mass basis.
[2a]
 Compared to the 
HiPCO SWNTs, pristine LV nanotubes grown at a synthesis temperature of 950 °C exhibited 
two-fold higher brightness in NIR-IIb region on the per mass basis, and the separated 
semiconducting LV SWNTs showed three times higher brightness in NIR-IIb region (d). 
  
 
600 800 1000 1200 1400
0.0
0.5
1.0
1.5
 
 
 
A
b
s
o
rb
a
n
c
e
 (
O
D
)
 OD 0.1
 OD 0.08
 OD 0.06
 OD 0.04
 OD 0.02
Wavelength (nm)
600 700 800 900 1000 1100
0.00
0.05
0.10
0.15
 
 
A
b
s
o
rb
a
n
c
e
 (
O
D
)
Wavelength (nm)
 OD 0.1
 OD 0.08
 OD 0.06
 OD 0.04
 OD 0.02
1000 1200 1400 1600 1800
0.0
5.0x10
3
1.0x10
4
1.5x10
4
2.0x10
4
 
 
In
te
g
ra
te
d
 P
L
 I
n
te
n
s
it
y
 (
a
.u
.)
Wavelength (nm)
 OD 0.1
 OD 0.08
 OD 0.06
 OD 0.04
 OD 0.02
1000 1200 1400 1600 1800
0.0
5.0x10
4
1.0x10
5
1.5x10
5
2.0x10
5
2.5x10
5
Wavelength (nm)
In
te
g
ra
te
d
 P
L
 I
n
te
n
s
it
y
 (
a
.u
.)
 
 
 OD 0.1
 OD 0.08
 OD 0.06
 OD 0.04
 OD 0.02
0.02 0.04 0.06 0.08 0.10 0.12
1.0x10
6
1.5x10
6
2.0x10
6
2.5x10
6
3.0x10
6
3.5x10
6
4.0x10
6
4.5x10
6
 data
 fit
 
 
 
 
Absorbance (OD)
In
te
g
ra
te
d
 P
L
 I
n
te
n
s
it
y
 (
a
.u
.)
0.02 0.04 0.06 0.08 0.10 0.12
0
1x10
5
2x10
5
3x10
5
4x10
5
5x10
5
6x10
5
 
 
In
te
g
ra
te
d
 P
L
 I
n
te
n
s
it
y
 (
a
.u
.)
Absorbance (OD)
 data
 fit
Slope=35972100
R2= 0.99726
Slope=5373590
R2= 0.99976
(a) (b)
(c) (d)
(e) (f)
808 nm 808 nm
 
Figure S3. Quantum yield measurement of semiconducting laser vaporization (LV) SWNTs 
using IR-26 in DCE (quantum yield of ~0.1%) as reference.
[5]
 The reported quantum yield 
values of IR-26 in DCE are not consistent in the literature, with variations up to an order of 
magnitude.
[7]
 Here, we chose the IR-26 quantum yield value from a recent study,
[5]
 which 
carefully discussed the important factors that may affect the quantum yield measurement.  (a) 
Optical absorbance spectra of a series of five solutions of IR-26 in DCE with absorbance 
values at 808 nm to be ~ 0.10, ~ 0.08, ~ 0.06, ~0.04 and ~0.02. (b) Optical absorbance spectra 
of a series of five semiconducting LV SWNTs solutions with absorbance values at 808 nm to 
be ~ 0.10, ~ 0.08, ~ 0.06, ~0.04 and ~0.02. (c) NIR fluorescence spectra of the five IR-26 
solutions in the range of 900-1800 nm under an excitation of 808 nm laser. (d) NIR 
fluorescence spectra of the five semiconducting LV SWNTs solutions in the range of 900-
1800 nm under an excitation of 808 nm laser. (e) The integrated emission intensities of five 
fluorescence spectra of IR-26 solutions plotted against the actual absorbances at 808 nm. The 
slope was obtained by linear fitting. (f) The integrated emission intensities of five 
fluorescence spectra of semiconducting LV SWNTs solutions plotted against the actual 
absorbances at 808 nm. The slope was obtained by linear fitting. The QY of semiconducting 
LV SWNTs was found to be ~0.01%. Although this QY was low, the LV SWNTs were found 
sufficiently bright for in vivo biological imaging in NIR-IIb region under an 808-nm laser 
excitation power density of 0.14 W/cm
2 
(well below the safe exposure limit of 0.33 W/cm
2 [8]
). 
The detailed measurements and calculation are shown in Method section. 
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Figure S4. To compare the photon scattering effects in NIR-II (1000-1700 nm), NIR-IIa 
(1300-1400 nm) and NIR-IIb (1500-1700 nm) regions, we performed a mock tissue phantom 
study by inserting a capillary tube filled with a mixture of HiPCO and semiconducting LV 
SWNTs under a piece of chicken breast with a thickness of ~ 4 mm. Due to the higher 
scattering of shorter wavelength photons by chicken tissues, images acquired in the NIR-II 
and NIR-IIa windows were more blurry than in NIR-IIb (a-c), with the apparent capillary tube 
width much wider compared to the tube width measured in the NIR-IIb window (2d-f). By 
measuring the Gaussian-fitted full width at half maximum (FWHM) of the cross-sectional 
intensity profiles, the apparent widths of the capillary tube imaged in NIR-II, IIa and IIb 
region were found to be broadened by 173%, 140% and 78%, respectively (g). For each NIR 
subregion, the percentage of broadening is calculated by dividing the FWHM width of the 
tube imaged under chicken breast (2.00, 1.75, 1.30 mm) by the FWHM width of the same 
tube imaged without chicken breast (0.73 mm) minus 100%. SBR analysis of the images is 
shown in h. Figure i shows a photo of the 4-mm thick chicken breast. 
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Figure S5. Photon scattering phantom study using intralipid. A capillary tube filled with a 
mixture of HiPCO and semiconducting LV SWNTs was immersed in a scattering medium, 
intralipid
[3]
 at various depths from 1 mm to 14 mm. Fluorescence images of the capillary tube 
were taken in NIR-II, IIa and IIb regions. Due to the much reduced scattering of photons, the 
tubes were clearly resolved in the images in NIR-IIb region with a clear and sharp resolution 
up to a penetration depth of 14 mm. In contrast, images taken in NIR-II and IIa regions 
became blurry with much loss of clarity, especially at depths > 7 mm.  
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Figure S6. To evaluate the accuracy of our vessel size measurements in the mouse, we 
studied light scattering effects in NIR-IIb region by intravenously injecting semiconducting 
LV SWNTs to a mouse tail vein and slicing a piece of ~2.5 mm thick hindlimb tissue from the 
mouse after dissection. We imaged a blood vessel (at the tissue surface) using a low-
magnification mode in the NIR-IIb region (a, pixel size ~78 µm). Then the whole hindlimb 
piece was flipped over and the same blood vessel was imaged through the 2.5 mm thick tissue 
(b, please note that a and b are bilateral symmetric). A broadening of ~44% in vessel size was 
measured due to the light scattering caused by the ~2.5 mm thick tissue (c-d).  
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Figure S7. Mouse hindlimb imaging in the 1500-1700 nm NIR-IIb region using HiPCO and 
LV SWNTs. (a-d) Time-course images of video-rate hindlimb fluorescence imaging in the 
NIR-IIb region using semiconducting LV SWNTs as emitters (data also shown in the Figure 4 
in the main text). (e-h) Time-course images of video-rate hindlimb fluorescence imaging in 
the NIR-IIb region using HiPCO SWNTs as emitters. (i-j) Rescaled d and h (images taken at 
~25.8 s post injection of LV SWNTs and HiPCO SWNTs) based on the maximum 
fluorescence intensity in each image. The average fluorescence intensity of femoral vessels in 
i is ~ three times higher than the one measured in j, suggesting the benefit of using 
semiconducting LV SWNTs with larger average diameter as NIR-IIb emitters. (k-l) Cross-
sectional intensity profiles of three small vessels marked in i and j. The apparent widths of 
these vessels were measured to be 94.7, 87.6, 82.5 µm, respectively by full width at half 
maximum (FWHM) in k using semiconducting LV SWNTs. However, these vessels were not 
well resolved in l when using HiPCO SWNTs as emitters, due to the low signal to 
background ratios caused by the lack of large diameter nanotubes emitting in the 1500-1700 
nm NIR-IIb region. Here imaging conditions for HiPCO SWNTs and semiconducting LV 
SWNTs, such as SWNT injection dose, laser power density, imaging exposure time and frame 
rate, 2D InGaAs detector and emission filters, are the same. 
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Figure S8. Blood flow speed quantification in various hindlimb arterial vessels based on real-
time NIR-IIb hindlimb fluorescence imaging. (a) A NIR-IIb fluorescence image of hindlimb 
vessels after intravenously injecting a solution of semiconducting LV SWNTs. The blood 
flow velocities of the femoral artery (labeled b) and deeper, higher-order arterial branches 
(labeled c-h) are quantified in Figure b and c-h respectively. (b-h) Blood flow velocity 
quantification by plotting the distance travelled by blood front against time. In each plot, the 
flow distance shows a linear increase versus time, exhibiting blood flow speeds of 22.6 mm/s 
in the femoral artery and 1.1-4.8 mm/s in the smaller arterial branches. 
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Figure S9. To verify the accuracy of our fluorescence-based velocity measurements, we 
compared the femoral vessel blood velocities of another mouse measured by both video-rate 
NIR-IIb fluorescence imaging method (a) and ultrasound method (b) side by side.
[4]
 
Ultrasound method is known to be the gold standard for in vivo blood flowmetry. We found 
that the Doppler-derived velocity measured by ultrasound method agreed well with the one 
measured by video-rate fluorescence imaging method (calculated based on the method 
described in a previous study
[4]
) with a deviation of ~ 20 %. We attribute this deviation to the 
slight change in mouse body temperature caused by different levels of anaesthesia during 
fluorescence imaging and ultrasound imaging. Meanwhile, we found that the blood velocities 
in the smaller arterial branches were hard to measure using ultrasound method due to the 
small dynamic range and low spatial resolution, showing the advantageous of NIR-IIb 
fluorescence imaging by providing a broader blood velocity dynamic range with high 
resolution. 
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Figure S10. To compare the wavelength-dependent fluorescence-based tumor imaging, we 
performed tumor imaging in both 1000-1700 nm NIR-II region
[9]
 and 1500-1700 nm NIR-IIb 
region on the same group of mice (n=2) side by side using HiPCO SWNTs and 
semiconducting LV SWNTs as emitters respectively. We first performed video-rate tumor 
imaging in the NIR-II region on a tumor bearing balb/c mouse by intravenously injecting 200 
µL of biocompatible HiPCO SWNT solution
[9]
 (with confined emission in the range of 1000-
1400 nm) and the time-course images are shown in a-f. Although the major organs (such as 
lungs and kidneys) showed up with a modest imaging contrast shortly after injection, the 
vessels structure surrounding the tumor area and the rest of mouse body, which appeared 
prominently when imaged at video rate in the NIR-IIb region using semiconducting LV 
SWNTs (Figure 5 in the main text), exhibited greater loss of clarity in the NIR-II region due 
to the much increased light scattering from photons shorten than 1400 nm that travel through 
mouse tissues. To further compare wavelength-dependent tumor imaging on the same mouse 
side by side, we intravenously injected another 200 µL of semiconducting LV SWNT solution 
into the same mouse as NIR-IIb emitters and compared the tumor-bearing mouse in both NIR-
II (g) and NIR-IIb (h) regions side by side. Quantitatively, the number of vessels resolved in 
the NIR-IIb region was found to much higher than the ones resolved in NIR-II, demonstrating 
of the benefit of higher imaging resolution with deep penetration due to the reduced light 
scattering in this long wavelength NIR-IIb region. Therefore although imaging of tumors and 
inner organs is achievable in shorter wavelength regions such as NIR-II region (as shown in 
both Figure S10 and a previous paper by our group
[9]
), imaging in the NIR-IIb region is 
advantageous due to the reduced light scattering, resolving fine features with higher resolution 
and deeper tissue penetration, beneficial for biomedical applications. 
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Figure S11. To study the clearance of SWNTs from mouse blood circulatory system, we 
performed an experiment by intravenously injecting semiconducting LV SWNTs to a group 
of balb/c mice (n=2) and collecting blood at various time points post injection (up to 30 
hours).
[9-10]
 By measuring SWNT concentration in each blood sample (mixed with tissue lysis 
buffer) based on the fluorescence intensity in the NIR-IIb region, we estimated the half-life of 
SWNT blood circulation to be ~ 5.6 hours (a). We further studied the biodistribution of 
semiconducting LV SWNTs in mice.
[9-10]
 At 7 days post injection, the mice were sacrificed 
and all major organs were collected. Each organ was weighed before dissolving in 1 ml of 
Solvable with 2% sodium cholate solution. The resulting solutions were heating at 80 ˚C for 
overnight to fully dissolve the organs. The fluorescence intensity of each solution was 
measured and the SWNT uptake in each organ was calculated based on the fluorescence 
intensity of the injected solution (after dilution). The semiconducting LV SWNTs were found 
to be largely accumulated in liver (11 percent injected dose per gram, or 11% ID/gram) and 
spleen (14% ID/gram) of the reticuloendothelial system (RES) (b). The uptakes in other 
organs (such as lungs and muscles) were found to be about or less than 1% ID/gram. 
Autofluorescence from control mouse organs and blood was found to be extremely low in the 
long wavelength NIR-IIb window,
[11]
 which makes sure that the fluorescence from each 
organ/blood sample nearly all comes from SWNTs. The concentration of SWNTs in all organ 
and blood samples measured fell well within the linear range where the fluorescence intensity 
is proportional to the SWNT concentration.  
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